Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,3.136031674393987e-41,242.35658914728683,22602.909992194487,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPL23', 'RPS5', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",9.470815656669841e-39,0,0,64
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.1509143309415868e-26,80.16044776119404,4787.715465873005,"['NDUFB9', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX4I1', 'COX17', 'NDUFB3', 'NDUFB2', 'ATP5MC3', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'ATP5F1B', 'UCP3', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'COX8A', 'ATP5PF', 'NDUFA7', 'NDUFA6', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'SLC25A5', 'SLC25A6']",1.737880639721796e-24,0,0,44
3,Nonalcoholic fatty liver disease WP4396,1.779405531025996e-18,17.544593345656192,717.0519571818157,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'UQCRFS1', 'CYC1', 'COX8A', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",1.7912682345661695e-16,0,0,39
4,Oxidative phosphorylation WP623,6.652883324732047e-12,25.65352449223417,660.2183565453963,"['NDUFB9', 'ATP5PF', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFB2', 'ATP5MC3', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1', 'ATP5F1B', 'NDUFS6', 'NDUFS5', 'ATP5MF', 'ATP5ME']",5.022926910172695e-10,0,0,22
5,Mitochondrial complex I assembly model OXPHOS system WP4324,2.8372992260890213e-10,31.275800711743774,687.5358740951383,"['NDUFB9', 'NDUFA13', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFA3', 'NDUFB3', 'NDUFA2', 'NDUFB2', 'NDUFA1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFAF3']",1.713728732557769e-08,0,0,18
6,Mitochondrial CIV Assembly WP4922,2.704250571237585e-09,51.876106194690266,1023.434701211099,"['COX8A', 'COA3', 'COX7B', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX7C', 'COX6B1', 'SCO2', 'COX14']",1.3611394541895844e-07,0,0,15
7,Mitochondrial complex III assembly WP4921,7.232959036367171e-06,inf,inf,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.00031205051842612654,0,0,8
8,Cholesterol Biosynthesis Pathway WP197,0.0007927449831311765,20.425087108013937,145.83530522559428,"['IDI1', 'SQLE', 'HMGCS1', 'MSMO1', 'HMGCR', 'FDFT1']",0.026600998322846146,0,0,6
9,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.0007927449831311765,20.425087108013937,145.83530522559428,"['IDI1', 'SQLE', 'HMGCS1', 'MSMO1', 'HMGCR', 'FDFT1']",0.026600998322846146,0,0,6
10,Selenium Micronutrient Network WP15,0.0017739211753851547,4.180042960359305,26.47874476177183,"['SELENOM', 'PRDX5', 'GPX4', 'PRDX1', 'SELENOW', 'SELENOK', 'SEPHS2', 'LDLR', 'SELENOH', 'SOD1', 'MSRB1']",0.05357241949663167,0,0,11
11,Eukaryotic Transcription Initiation WP405,0.0030089200771491824,16.991304347826087,98.65447026027007,"['TAF13', 'TAF7', 'POLR2I', 'POLR3K', 'POLR2K']",0.08260853302718664,0,0,5
12,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.00619305330794223,6.801393728222997,34.58051010527287,"['IDI1', 'SQLE', 'HMGCS1', 'HMGCR', 'LDLR', 'FDFT1']",0.15585850824987946,0,0,6
13,Integrated breast cancer pathway WP1984,0.007040420835276758,3.412280701754386,16.911561162129686,"['GADD45A', 'TRADD', 'DCAKD', 'ODC1', 'BAX', 'PHB', 'FADD', 'BRCA1', 'HMGCR', 'FAU']",0.1635543917118139,0,0,10
14,Androgen receptor signaling pathway WP138,0.00981464640213261,3.892107892107892,17.99663780916243,"['KAT5', 'PRDX1', 'BAG1', 'STUB1', 'BRCA1', 'PARK7', 'CALR', 'FKBP4']",0.21171594381743203,0,0,8
15,Statin inhibition of cholesterol production WP430,0.011117630034261273,13.569444444444445,61.05195843175073,"['SQLE', 'HMGCR', 'LDLR', 'FDFT1']",0.21191836347258647,0,0,4
16,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.011929179400774734,inf,inf,"['HMGCS1', 'HMGCR', 'LDLR']",0.21191836347258647,0,0,3
17,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.011929179400774734,inf,inf,"['IDI1', 'HMGCS1', 'HMGCR']",0.21191836347258647,0,0,3
18,mRNA Processing WP411,0.01853670668769798,5.6579710144927535,22.564001800665828,"['SF3B5', 'LSM7', 'SNRPE', 'SNU13', 'SRSF9']",0.31100474553804386,0,0,5
19,Pyrimidine metabolism WP4022,0.023950060316514313,3.024087024087024,11.285240891694865,"['POLE3', 'NME2', 'POLR2I', 'DCTPP1', 'POLR3K', 'POLR2K', 'NME1', 'POLR2L']",0.3806799060835433,0,0,8
20,Nanomaterial induced apoptosis WP2507,0.02733509343806827,6.78125,24.409678514350844,"['ENDOG', 'BAX', 'CYCS', 'FADD']",0.4127599109148309,0,0,4
21,Apoptosis Modulation and Signaling WP1772,0.03612298363373663,3.3954703832752613,11.275766162848031,"['ENDOG', 'IL1R1', 'TRADD', 'CYCS', 'BAX', 'FADD']",0.5071540614045701,0,0,6
22,BDNF-TrkB Signaling WP3676,0.039561475907089604,10.15944540727903,32.813987284220424,"['TRPC3', 'HOMER1', 'HRAS']",0.5071540614045701,0,0,3
23,Histone Modifications WP2369,0.039561475907089604,10.15944540727903,32.813987284220424,"['SET', 'H3F3B', 'H3F3A']",0.5071540614045701,0,0,3
24,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.052278146257579004,inf,inf,"['COX8A', 'GSTP1']",0.5071540614045701,0,0,2
25,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.052278146257579004,inf,inf,"['HOMER1', 'HRAS']",0.5071540614045701,0,0,2
26,Cellular Proteostasis WP4918,0.052278146257579004,inf,inf,"['VBP1', 'PFDN6']",0.5071540614045701,0,0,2
27,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.052278146257579004,inf,inf,"['H3F3B', 'H3F3A']",0.5071540614045701,0,0,2
28,SARS-CoV-2 mitochondrial interactions WP5038,0.052278146257579004,inf,inf,"['NDUFB9', 'PHB']",0.5071540614045701,0,0,2
29,Copper homeostasis WP3286,0.052382748753852126,4.518518518518518,13.325915245262243,"['SCO2', 'COX17', 'ATOX1', 'SOD1']",0.5071540614045701,0,0,4
30,DNA IR-double strand breaks and cellular response via ATM WP3959,0.052382748753852126,4.518518518518518,13.325915245262243,"['YAP1', 'KAT5', 'BAX', 'BRCA1']",0.5071540614045701,0,0,4
31,Folate Metabolism WP176,0.052382748753852126,4.518518518518518,13.325915245262243,"['AHCY', 'GPX4', 'LDLR', 'SOD1']",0.5071540614045701,0,0,4
32,Synaptic Vesicle Pathway WP2267,0.05541749677599607,3.391304347826087,9.810568386399142,"['SLC32A1', 'PARK7', 'AP2M1', 'VAMP2', 'CPLX3']",0.5071540614045701,0,0,5
33,Proteasome Degradation WP183,0.05541749677599607,3.391304347826087,9.810568386399142,"['PSMD8', 'PSMB6', 'H2AFZ', 'HLA-B', 'PSMB10']",0.5071540614045701,0,0,5
34,VEGFA-VEGFR2 Signaling Pathway WP3888,0.06721959347648311,1.5590339892665475,4.2090651601973486,"['SET', 'SSR4', 'TRPC3', 'RPL13A', 'RPL10A', 'ETS1', 'RPL7', 'DNAJA1', 'LDHA', 'RPL18A', 'TMSB4X', 'RPLP2', 'CYCS', 'RPL27', 'SH3BGRL3', 'RPL26', 'FADD', 'CALR', 'CCT7', 'HRAS', 'SLC25A25']",0.5970681538205265,0,0,21
35,7q11.23 copy number variation syndrome WP4932,0.07118518266200792,2.3760907504363002,6.278749929340968,"['ATP5F1B', 'EIF4H', 'ATP5MC3', 'ATP5F1D', 'VAMP2', 'ATP5F1E', 'ATP5MC1']",0.5971645878868442,0,0,7
36,Ciliary landscape WP4352,0.07118518266200792,2.3760907504363002,6.278749929340968,"['PSMD8', 'YAP1', 'EXOSC4', 'H3F3A', 'COPS7A', 'COX6C', 'LSM4']",0.5971645878868442,0,0,7
37,Vitamin B12 metabolism WP1533,0.08222729936767185,5.077123050259965,12.684013657386608,"['CUBN', 'LDLR', 'SOD1']",0.6115718631393099,0,0,3
38,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.08222729936767185,5.077123050259965,12.684013657386608,"['H3F3B', 'H2AFZ', 'H3F3A']",0.6115718631393099,0,0,3
39,p38 MAPK Signaling Pathway WP400,0.08222729936767185,5.077123050259965,12.684013657386608,"['TRADD', 'DDIT3', 'HRAS']",0.6115718631393099,0,0,3
40,Cytosolic DNA-sensing pathway WP4655,0.08302796817454207,2.8246376811594205,7.029330519005214,"['TRADD', 'FADD', 'POLR3K', 'POLR2K', 'POLR2L']",0.6115718631393099,0,0,5
41,Melanoma WP4685,0.08302796817454207,2.8246376811594205,7.029330519005214,"['GADD45A', 'BAX', 'CALM3', 'ETS1', 'HRAS']",0.6115718631393099,0,0,5
42,Genotoxicity pathway WP4286,0.08622882336748772,3.3871527777777777,8.301067310055988,"['RPS27', 'GADD45A', 'TRIAP1', 'PHLDA3']",0.6200263013566975,0,0,4
43,Apoptosis WP254,0.12803886392872207,2.7083333333333335,5.5667663910732035,"['TRADD', 'CYCS', 'BAX', 'FADD']",0.7394660859093485,0,0,4
44,Amyotrophic lateral sclerosis (ALS) WP2447,0.13297613923893334,6.7612456747404845,13.641391715841483,"['BAX', 'SOD1']",0.7394660859093485,0,0,2
45,TP53 network WP1742,0.13297613923893334,6.7612456747404845,13.641391715841483,"['GADD45A', 'BAX']",0.7394660859093485,0,0,2
46,Vitamin D-sensitive calcium signaling in depression WP4698,0.13297613923893334,6.7612456747404845,13.641391715841483,"['CALB1', 'GPX4']",0.7394660859093485,0,0,2
47,EV release from cardiac cells and their functional effects WP3297,0.13297613923893334,6.7612456747404845,13.641391715841483,"['CXCL12', 'RGS16']",0.7394660859093485,0,0,2
48,IL-1 signaling pathway WP195,0.13297613923893334,6.7612456747404845,13.641391715841483,"['IL1R1', 'HSPB2']",0.7394660859093485,0,0,2
49,Mevalonate pathway WP3963,0.13297613923893334,6.7612456747404845,13.641391715841483,"['HMGCS1', 'HMGCR']",0.7394660859093485,0,0,2
50,Nanoparticle triggered regulated necrosis WP2513,0.13297613923893334,6.7612456747404845,13.641391715841483,"['TRADD', 'FADD']",0.7394660859093485,0,0,2
51,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.13297613923893334,6.7612456747404845,13.641391715841483,"['YAP1', 'FERMT3']",0.7394660859093485,0,0,2
52,Glycolysis in senescence WP5049,0.13711953910901825,3.383015597920277,6.721721084621291,"['LDHA', 'PKM', 'ALDOC']",0.7394660859093485,0,0,3
53,MET in type 1 papillary renal cell carcinoma WP4205,0.13711953910901825,3.383015597920277,6.721721084621291,"['RPL11', 'ETS1', 'HRAS']",0.7394660859093485,0,0,3
54,Parkinson's disease pathway WP2371,0.13711953910901825,3.383015597920277,6.721721084621291,"['PINK1', 'CYCS', 'PARK7']",0.7394660859093485,0,0,3
55,Photodynamic therapy-induced unfolded protein response WP3613,0.13711953910901825,3.383015597920277,6.721721084621291,"['XBP1', 'DDIT3', 'CALR']",0.7394660859093485,0,0,3
56,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.13711953910901825,3.383015597920277,6.721721084621291,"['CXCL12', 'TRADD', 'FADD']",0.7394660859093485,0,0,3
57,16p11.2 proximal deletion syndrome WP4949,0.15533356753942976,2.116304347826087,3.940940531474994,"['TCP1', 'KCTD13', 'SEZ6L2', 'CCT7', 'CDIPT']",0.7978316867625944,0,0,5
58,DNA Repair Pathways Full Network WP4946,0.19860249935305027,1.8801932367149758,3.039238249547885,"['NEIL2', 'CENPX', 'TDG', 'POLE3', 'BRCA1']",0.7978316867625944,0,0,5
59,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.20067214685040485,2.535961871750433,4.072964776207005,"['PPP1R14B', 'XBP1', 'DDIT3']",0.7978316867625944,0,0,3
60,Leptin signaling pathway WP2034,0.20067214685040485,2.535961871750433,4.072964776207005,"['CFL2', 'BAX', 'HRAS']",0.7978316867625944,0,0,3
61,Mesodermal commitment pathway WP2857,0.20067214685040485,2.535961871750433,4.072964776207005,"['YAP1', 'SLC2A12', 'RPL38']",0.7978316867625944,0,0,3
62,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.20067214685040485,2.535961871750433,4.072964776207005,"['IFI27L2', 'ETS1', 'HRAS']",0.7978316867625944,0,0,3
63,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.20067214685040485,2.535961871750433,4.072964776207005,"['CXCL12', 'TRADD', 'FADD']",0.7978316867625944,0,0,3
64,Target Of Rapamycin (TOR) Signaling WP1471,0.22639081636180583,3.378892733564014,5.019319804717776,"['IDI1', 'HMGCR']",0.7978316867625944,0,0,2
65,Tumor suppressor activity of SMARCB1 WP4204,0.22639081636180583,3.378892733564014,5.019319804717776,"['H3F3B', 'H3F3A']",0.7978316867625944,0,0,2
66,GABA receptor Signaling WP4159,0.22639081636180583,3.378892733564014,5.019319804717776,"['SLC32A1', 'AP2M1']",0.7978316867625944,0,0,2
67,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.22639081636180583,3.378892733564014,5.019319804717776,"['BAX', 'FADD']",0.7978316867625944,0,0,2
68,Methionine De Novo and Salvage Pathway WP3580,0.22639081636180583,3.378892733564014,5.019319804717776,"['AHCY', 'ODC1']",0.7978316867625944,0,0,2
69,Nucleotide metabolism WP404,0.22639081636180583,3.378892733564014,5.019319804717776,"['NME2', 'OAZ1']",0.7978316867625944,0,0,2
70,Oxidative Stress WP408,0.22639081636180583,3.378892733564014,5.019319804717776,"['TXN2', 'SOD1']",0.7978316867625944,0,0,2
71,15q11.2 copy number variation syndrome WP4940,0.22879660684062608,inf,inf,['TUBGCP4'],0.7978316867625944,0,0,1
72,Serotonin and anxiety WP3947,0.22879660684062608,inf,inf,['CRH'],0.7978316867625944,0,0,1
73,Serotonin and anxiety-related events WP3944,0.22879660684062608,inf,inf,['CRH'],0.7978316867625944,0,0,1
74,Serotonin Transporter Activity WP1455,0.22879660684062608,inf,inf,['IL1R1'],0.7978316867625944,0,0,1
75,Vitamin B12 Disorders WP4271,0.22879660684062608,inf,inf,['CUBN'],0.7978316867625944,0,0,1
76,Composition of Lipid Particles WP3601,0.22879660684062608,inf,inf,['LDLR'],0.7978316867625944,0,0,1
77,Cytosine methylation WP3585,0.22879660684062608,inf,inf,['TDG'],0.7978316867625944,0,0,1
78,Energy Metabolism WP1541,0.22879660684062608,inf,inf,['UCP3'],0.7978316867625944,0,0,1
79,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.22879660684062608,inf,inf,['MAFF'],0.7978316867625944,0,0,1
80,Glycerophospholipid Biosynthetic Pathway WP2533,0.22879660684062608,inf,inf,['CDIPT'],0.7978316867625944,0,0,1
81,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.22879660684062608,inf,inf,['ELOB'],0.7978316867625944,0,0,1
82,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.22879660684062608,inf,inf,['HRAS'],0.7978316867625944,0,0,1
83,Mitochondrial CII Assembly WP4920,0.22879660684062608,inf,inf,['SDHAF1'],0.7978316867625944,0,0,1
84,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.22879660684062608,inf,inf,['LDHA'],0.7978316867625944,0,0,1
85,TNF-alpha signaling pathway WP231,0.22983892963028382,1.9325396825396826,2.8415609757699816,"['TRADD', 'BAX', 'FADD', 'HRAS']",0.7978316867625944,0,0,4
86,Translation Factors WP107,0.22983892963028382,1.9325396825396826,2.8415609757699816,"['EEF1B2', 'EEF1G', 'EIF3I', 'EIF4H']",0.7978316867625944,0,0,4
87,Non-small cell lung cancer WP4255,0.22983892963028382,1.9325396825396826,2.8415609757699816,"['GADD45A', 'CYCS', 'BAX', 'HRAS']",0.7978316867625944,0,0,4
88,Base Excision Repair WP4752,0.2693381402219991,2.027729636048527,2.659950718297266,"['NEIL2', 'TDG', 'POLE3']",0.8935968902941892,0,0,3
89,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.2693381402219991,2.027729636048527,2.659950718297266,"['LDHA', 'PKM', 'BAX']",0.8935968902941892,0,0,3
90,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.2693381402219991,2.027729636048527,2.659950718297266,"['YAP1', 'BAX', 'HRAS']",0.8935968902941892,0,0,3
91,Alzheimer's disease WP2059,0.28649261690496897,1.6901041666666667,2.112702059942355,"['ATP5MD', 'CYCS', 'CALM3', 'FADD']",0.8935968902941892,0,0,4
92,DNA damage response WP707,0.28649261690496897,1.6901041666666667,2.112702059942355,"['GADD45A', 'CYCS', 'BAX', 'BRCA1']",0.8935968902941892,0,0,4
93,Glycolysis and Gluconeogenesis WP534,0.28649261690496897,1.6901041666666667,2.112702059942355,"['LDHA', 'PKM', 'PGAM1', 'ALDOC']",0.8935968902941892,0,0,4
94,miRNA regulation of DNA damage response WP1530,0.28649261690496897,1.6901041666666667,2.112702059942355,"['GADD45A', 'CYCS', 'BAX', 'BRCA1']",0.8935968902941892,0,0,4
95,Apoptosis Modulation by HSP70 WP384,0.3224998120428268,2.251441753171857,2.547850196415211,"['CYCS', 'FADD']",0.8935968902941892,0,0,2
96,ATM Signaling Pathway WP2516,0.3224998120428268,2.251441753171857,2.547850196415211,"['GADD45A', 'BRCA1']",0.8935968902941892,0,0,2
97,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.3224998120428268,2.251441753171857,2.547850196415211,"['BANF1', 'HRAS']",0.8935968902941892,0,0,2
98,Imatinib and Chronic Myeloid Leukemia WP3640,0.3224998120428268,2.251441753171857,2.547850196415211,"['SPRED2', 'GADD45A']",0.8935968902941892,0,0,2
99,Amino Acid metabolism WP3925,0.3399877650517698,1.6889081455805892,1.8220712013148213,"['LDHA', 'PKM', 'ODC1']",0.8935968902941892,0,0,3
100,Fas ligand pathway and stress induction of heat shock proteins WP314,0.3399877650517698,1.6889081455805892,1.8220712013148213,"['MAPKAPK3', 'CYCS', 'FADD']",0.8935968902941892,0,0,3
101,Metabolic reprogramming in colon cancer WP4290,0.3399877650517698,1.6889081455805892,1.8220712013148213,"['LDHA', 'PKM', 'PGAM1']",0.8935968902941892,0,0,3
102,Senescence and Autophagy in Cancer WP615,0.3895858805067266,1.266768292682927,1.194145668461388,"['GABARAPL2', 'GABARAPL1', 'MAP1LC3B', 'IGFBP5', 'HRAS', 'GABARAP']",0.8935968902941892,0,0,6
103,IL-18 signaling pathway WP4754,0.3927348607510714,1.1617420913884007,1.0857880316821333,"['ARL4D', 'IMP3', 'TMSB4X', 'RGS16', 'COX17', 'CYCS', 'BAX', 'NDUFC1', 'FADD', 'RND2', 'ITM2C']",0.8935968902941892,0,0,11
104,Exercise-induced Circadian Regulation WP410,0.40325870510004674,1.3506944444444444,1.226669594511641,"['DNAJA1', 'IDI1', 'GSTP1', 'UCP3']",0.8935968902941892,0,0,4
105,Hepatitis B infection WP4666,0.40325870510004674,1.3506944444444444,1.226669594511641,"['CYCS', 'BAX', 'FADD', 'HRAS']",0.8935968902941892,0,0,4
106,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.40531492540978536,3.3747841105354057,3.0477368886712695,['HRAS'],0.8935968902941892,0,0,1
107,Autophagy WP4923,0.40531492540978536,3.3747841105354057,3.0477368886712695,['MAP1LC3B'],0.8935968902941892,0,0,1
108,Trans-sulfuration and one-carbon metabolism WP2525,0.40531492540978536,3.3747841105354057,3.0477368886712695,['AHCY'],0.8935968902941892,0,0,1
109,Transcriptional cascade regulating adipogenesis WP4211,0.40531492540978536,3.3747841105354057,3.0477368886712695,['DDIT3'],0.8935968902941892,0,0,1
110,Dopamine metabolism WP2436,0.40531492540978536,3.3747841105354057,3.0477368886712695,['SOD1'],0.8935968902941892,0,0,1
111,Ebstein-Barr virus LMP1 signaling WP262,0.40531492540978536,3.3747841105354057,3.0477368886712695,['TRADD'],0.8935968902941892,0,0,1
112,Fluoropyrimidine Activity WP1601,0.40531492540978536,3.3747841105354057,3.0477368886712695,['TDG'],0.8935968902941892,0,0,1
113,Gastric Cancer Network 2 WP2363,0.40531492540978536,3.3747841105354057,3.0477368886712695,['SNURF'],0.8935968902941892,0,0,1
114,Glycerolipids and Glycerophospholipids WP4722,0.40531492540978536,3.3747841105354057,3.0477368886712695,['CDIPT'],0.8935968902941892,0,0,1
115,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.40531492540978536,3.3747841105354057,3.0477368886712695,['LTBP1'],0.8935968902941892,0,0,1
116,IL-2 signaling pathway WP49,0.40531492540978536,3.3747841105354057,3.0477368886712695,['HRAS'],0.8935968902941892,0,0,1
117,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.40531492540978536,3.3747841105354057,3.0477368886712695,['BAX'],0.8935968902941892,0,0,1
118,MAPK Cascade WP422,0.40531492540978536,3.3747841105354057,3.0477368886712695,['HRAS'],0.8935968902941892,0,0,1
119,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.40531492540978536,3.3747841105354057,3.0477368886712695,['AHCY'],0.8935968902941892,0,0,1
120,miR-509-3p alteration of YAP1/ECM axis WP3967,0.40531492540978536,3.3747841105354057,3.0477368886712695,['YAP1'],0.8935968902941892,0,0,1
121,miRNA regulation of p53 pathway in prostate cancer WP3982,0.40531492540978536,3.3747841105354057,3.0477368886712695,['BAX'],0.8935968902941892,0,0,1
122,MTHFR deficiency WP4288,0.40531492540978536,3.3747841105354057,3.0477368886712695,['CYCS'],0.8935968902941892,0,0,1
123,Nanoparticle-mediated activation of receptor signaling WP2643,0.40531492540978536,3.3747841105354057,3.0477368886712695,['HRAS'],0.8935968902941892,0,0,1
124,Overview of nanoparticle effects WP3287,0.40531492540978536,3.3747841105354057,3.0477368886712695,['BAX'],0.8935968902941892,0,0,1
125,PDGF Pathway WP2526,0.40531492540978536,3.3747841105354057,3.0477368886712695,['HRAS'],0.8935968902941892,0,0,1
126,PDGFR-beta pathway WP3972,0.40531492540978536,3.3747841105354057,3.0477368886712695,['HRAS'],0.8935968902941892,0,0,1
127,Peroxiredoxin 2 induced ovarian failure WP4873,0.40531492540978536,3.3747841105354057,3.0477368886712695,['BAX'],0.8935968902941892,0,0,1
128,PKC-gamma calcium signaling pathway in ataxia WP4760,0.40531492540978536,3.3747841105354057,3.0477368886712695,['TRPC3'],0.8935968902941892,0,0,1
129,RalA downstream regulated genes WP2290,0.40531492540978536,3.3747841105354057,3.0477368886712695,['HRAS'],0.8935968902941892,0,0,1
130,"Relationship between inflammation, COX-2 and EGFR WP4483",0.40531492540978536,3.3747841105354057,3.0477368886712695,['HRAS'],0.8935968902941892,0,0,1
131,Unfolded protein response WP4925,0.41518991449305215,1.6877162629757785,1.4835350636867253,"['XBP1', 'DDIT3']",0.8935968902941892,0,0,2
132,Cori Cycle WP1946,0.41518991449305215,1.6877162629757785,1.4835350636867253,"['LDHA', 'PGAM1']",0.8935968902941892,0,0,2
133,Integrated Cancer Pathway WP1971,0.41518991449305215,1.6877162629757785,1.4835350636867253,"['BAX', 'BRCA1']",0.8935968902941892,0,0,2
134,MECP2 and Associated Rett Syndrome WP3584,0.41518991449305215,1.6877162629757785,1.4835350636867253,"['GABRR2', 'OPRK1']",0.8935968902941892,0,0,2
135,One-carbon metabolism and related pathways WP3940,0.41518991449305215,1.6877162629757785,1.4835350636867253,"['GPX4', 'SOD1']",0.8935968902941892,0,0,2
136,p53 transcriptional gene network WP4963,0.41518991449305215,1.6877162629757785,1.4835350636867253,"['GADD45A', 'BAX']",0.8935968902941892,0,0,2
137,Pathways affected in adenoid cystic carcinoma WP3651,0.41518991449305215,1.6877162629757785,1.4835350636867253,"['BRCA1', 'HRAS']",0.8935968902941892,0,0,2
138,Acute viral myocarditis WP4298,0.4776621441025285,1.2653812824956672,0.9349289951793512,"['ENDOG', 'CYCS', 'BAX']",0.8935968902941892,0,0,3
139,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.4776621441025285,1.2653812824956672,0.9349289951793512,"['GADD45A', 'CYCS', 'BAX']",0.8935968902941892,0,0,3
140,Endoderm differentiation WP2853,0.4776621441025285,1.2653812824956672,0.9349289951793512,"['TCEAL2', 'SLC2A12', 'NME1']",0.8935968902941892,0,0,3
141,Endometrial cancer WP4155,0.4776621441025285,1.2653812824956672,0.9349289951793512,"['GADD45A', 'BAX', 'HRAS']",0.8935968902941892,0,0,3
142,Sleep regulation WP3591,0.5009969758561446,1.3494809688581315,0.9327008079965418,"['AHCY', 'CRH']",0.8935968902941892,0,0,2
143,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.5009969758561446,1.3494809688581315,0.9327008079965418,"['HRAS', 'LTBP1']",0.8935968902941892,0,0,2
144,TGF-beta Receptor Signaling WP560,0.5009969758561446,1.3494809688581315,0.9327008079965418,"['HRAS', 'LTBP1']",0.8935968902941892,0,0,2
145,Thermogenesis WP4321,0.5009969758561446,1.3494809688581315,0.9327008079965418,"['CPT1B', 'HRAS']",0.8935968902941892,0,0,2
146,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.5009969758561446,1.3494809688581315,0.9327008079965418,"['HRAS', 'MYL12B']",0.8935968902941892,0,0,2
147,Computational Model of Aerobic Glycolysis WP4629,0.5009969758561446,1.3494809688581315,0.9327008079965418,"['LDHA', 'PKM']",0.8935968902941892,0,0,2
148,DNA Replication WP466,0.5009969758561446,1.3494809688581315,0.9327008079965418,"['GMNN', 'UBA52']",0.8935968902941892,0,0,2
149,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.5009969758561446,1.3494809688581315,0.9327008079965418,"['CD63', 'SOD1']",0.8935968902941892,0,0,2
150,Fragile X Syndrome  WP4549,0.5009969758561446,1.3494809688581315,0.9327008079965418,"['HOMER1', 'AP2M1']",0.8935968902941892,0,0,2
151,Galanin receptor pathway WP4970,0.5009969758561446,1.3494809688581315,0.9327008079965418,"['YAP1', 'VAMP2']",0.8935968902941892,0,0,2
152,PPAR signaling pathway WP3942,0.5009969758561446,1.3494809688581315,0.9327008079965418,"['FABP6', 'CPT1B']",0.8935968902941892,0,0,2
153,Myometrial relaxation and contraction pathways WP289,0.5245696921590773,1.0651017788373371,0.6871791559400633,"['IGFBP5', 'RGS16', 'MAFF', 'CRH', 'CALM3', 'IGFBP6']",0.8935968902941892,0,0,6
154,DNA damage response (only ATM dependent) WP710,0.5413852827229451,1.12420566146736,0.6898396713948075,"['BAX', 'HRAS', 'LDLR']",0.8935968902941892,0,0,3
155,Pathways in clear cell renal cell carcinoma WP4018,0.5413852827229451,1.12420566146736,0.6898396713948075,"['LDHA', 'PKM', 'ALDOC']",0.8935968902941892,0,0,3
156,Signal transduction through IL1R WP4496,0.5414842083570749,1.6865284974093264,1.0345863616785596,['IL1R1'],0.8935968902941892,0,0,1
157,Signaling of Hepatocyte Growth Factor Receptor WP313,0.5414842083570749,1.6865284974093264,1.0345863616785596,['HRAS'],0.8935968902941892,0,0,1
158,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.5414842083570749,1.6865284974093264,1.0345863616785596,['IL1R1'],0.8935968902941892,0,0,1
159,Urea cycle and metabolism of amino groups WP497,0.5414842083570749,1.6865284974093264,1.0345863616785596,['ODC1'],0.8935968902941892,0,0,1
160,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.5414842083570749,1.6865284974093264,1.0345863616785596,['VIP'],0.8935968902941892,0,0,1
161,Cysteine and methionine catabolism WP4504,0.5414842083570749,1.6865284974093264,1.0345863616785596,['AHCY'],0.8935968902941892,0,0,1
162,Disruption of postsynaptic signaling by CNV WP4875,0.5414842083570749,1.6865284974093264,1.0345863616785596,['HOMER1'],0.8935968902941892,0,0,1
163,Dual hijack model of Vif in HIV infection WP3300,0.5414842083570749,1.6865284974093264,1.0345863616785596,['ELOB'],0.8935968902941892,0,0,1
164,EDA signaling in hair follicle development WP3930,0.5414842083570749,1.6865284974093264,1.0345863616785596,['SOSTDC1'],0.8935968902941892,0,0,1
165,Fatty acid transporters WP5061,0.5414842083570749,1.6865284974093264,1.0345863616785596,['FABP6'],0.8935968902941892,0,0,1
166,Gastric acid production WP2596,0.5414842083570749,1.6865284974093264,1.0345863616785596,['VIP'],0.8935968902941892,0,0,1
167,Gastric Cancer Network 1 WP2361,0.5414842083570749,1.6865284974093264,1.0345863616785596,['H3F3A'],0.8935968902941892,0,0,1
168,Genes targeted by miRNAs in adipocytes WP1992,0.5414842083570749,1.6865284974093264,1.0345863616785596,['TMSB4X'],0.8935968902941892,0,0,1
169,Glutathione metabolism WP100,0.5414842083570749,1.6865284974093264,1.0345863616785596,['GPX4'],0.8935968902941892,0,0,1
170,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.5414842083570749,1.6865284974093264,1.0345863616785596,['LDHA'],0.8935968902941892,0,0,1
171,HIF1A and PPARG regulation of glycolysis WP2456,0.5414842083570749,1.6865284974093264,1.0345863616785596,['LDHA'],0.8935968902941892,0,0,1
172,IL1 and megakaryocytes in obesity WP2865,0.5414842083570749,1.6865284974093264,1.0345863616785596,['IL1R1'],0.8935968902941892,0,0,1
173,Interleukin-11 Signaling Pathway WP2332,0.5414842083570749,1.6865284974093264,1.0345863616785596,['HRAS'],0.8935968902941892,0,0,1
174,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.5414842083570749,1.6865284974093264,1.0345863616785596,['HRAS'],0.8935968902941892,0,0,1
175,Kit receptor signaling pathway WP304,0.5414842083570749,1.6865284974093264,1.0345863616785596,['HRAS'],0.8935968902941892,0,0,1
176,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.5414842083570749,1.6865284974093264,1.0345863616785596,['LDLR'],0.8935968902941892,0,0,1
177,Monoamine Transport WP727,0.5414842083570749,1.6865284974093264,1.0345863616785596,['IL1R1'],0.8935968902941892,0,0,1
178,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.5414842083570749,1.6865284974093264,1.0345863616785596,['EIF3I'],0.8935968902941892,0,0,1
179,One-carbon metabolism WP241,0.5414842083570749,1.6865284974093264,1.0345863616785596,['AHCY'],0.8935968902941892,0,0,1
180,Osteoclast Signaling WP12,0.5414842083570749,1.6865284974093264,1.0345863616785596,['ATP6V1G1'],0.8935968902941892,0,0,1
181,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.5414842083570749,1.6865284974093264,1.0345863616785596,['HRAS'],0.8935968902941892,0,0,1
182,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.5414842083570749,1.6865284974093264,1.0345863616785596,['BAX'],0.8935968902941892,0,0,1
183,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.5414842083570749,1.6865284974093264,1.0345863616785596,['CALM3'],0.8935968902941892,0,0,1
184,AGE/RAGE pathway WP2324,0.5782165342973636,1.1239907727797,0.6157298487712437,"['CYCS', 'SOD1']",0.9209792549979274,0,0,2
185,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.5782165342973636,1.1239907727797,0.6157298487712437,"['MAPKAPK3', 'HRAS']",0.9209792549979274,0,0,2
186,Ferroptosis WP4313,0.5782165342973636,1.1239907727797,0.6157298487712437,"['MAP1LC3B', 'GPX4']",0.9209792549979274,0,0,2
187,Modulators of TCR signaling and T cell activation WP5072,0.5782165342973636,1.1239907727797,0.6157298487712437,"['NDUFB10', 'ELOB']",0.9209792549979274,0,0,2
188,Oncostatin M Signaling Pathway WP2374,0.5782165342973636,1.1239907727797,0.6157298487712437,"['HRAS', 'LDLR']",0.9209792549979274,0,0,2
189,AMP-activated protein kinase (AMPK) signaling WP1403,0.6462818381913535,0.962926347009392,0.4203362125721932,"['HMGCR', 'CPT1B']",0.9209792549979274,0,0,2
190,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.6462818381913535,0.962926347009392,0.4203362125721932,"['BEX3', 'ETS1']",0.9209792549979274,0,0,2
191,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.6462818381913535,0.962926347009392,0.4203362125721932,"['BAX', 'HRAS']",0.9209792549979274,0,0,2
192,Head and Neck Squamous Cell Carcinoma WP4674,0.6462818381913535,0.962926347009392,0.4203362125721932,"['FADD', 'HRAS']",0.9209792549979274,0,0,2
193,Bile acids synthesis and enterohepatic circulation  WP4389,0.6465152386078166,1.1237766263673,0.4901447390590789,['LDLR'],0.9209792549979274,0,0,1
194,Trans-sulfuration pathway WP2333,0.6465152386078166,1.1237766263673,0.4901447390590789,['AHCY'],0.9209792549979274,0,0,1
195,Type 2 papillary renal cell carcinoma WP4241,0.6465152386078166,1.1237766263673,0.4901447390590789,['ELOB'],0.9209792549979274,0,0,1
196,White fat cell differentiation WP4149,0.6465152386078166,1.1237766263673,0.4901447390590789,['DDIT3'],0.9209792549979274,0,0,1
197,ERK Pathway in Huntington's Disease WP3853,0.6465152386078166,1.1237766263673,0.4901447390590789,['HRAS'],0.9209792549979274,0,0,1
198,Ethanol effects on histone modifications WP3996,0.6465152386078166,1.1237766263673,0.4901447390590789,['AHCY'],0.9209792549979274,0,0,1
199,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.6465152386078166,1.1237766263673,0.4901447390590789,['HRAS'],0.9209792549979274,0,0,1
200,Fatty acid beta-oxidation WP143,0.6465152386078166,1.1237766263673,0.4901447390590789,['CPT1B'],0.9209792549979274,0,0,1
201,Glycosylation and related congenital defects WP4521,0.6465152386078166,1.1237766263673,0.4901447390590789,['DPM3'],0.9209792549979274,0,0,1
202,"GPCRs, Class B Secretin-like WP334",0.6465152386078166,1.1237766263673,0.4901447390590789,['CALCR'],0.9209792549979274,0,0,1
203,Major receptors targeted by epinephrine and norepinephrine WP4589,0.6465152386078166,1.1237766263673,0.4901447390590789,['ADRA2A'],0.9209792549979274,0,0,1
204,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.6465152386078166,1.1237766263673,0.4901447390590789,['VEGFB'],0.9209792549979274,0,0,1
205,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.6465152386078166,1.1237766263673,0.4901447390590789,['SCO2'],0.9209792549979274,0,0,1
206,Neovascularisation processes WP4331,0.6465152386078166,1.1237766263673,0.4901447390590789,['CXCL12'],0.9209792549979274,0,0,1
207,Netrin-UNC5B signaling pathway WP4747,0.6465152386078166,1.1237766263673,0.4901447390590789,['YAP1'],0.9209792549979274,0,0,1
208,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.6465152386078166,1.1237766263673,0.4901447390590789,['GSTP1'],0.9209792549979274,0,0,1
209,RANKL/RANK signaling pathway WP2018,0.6465152386078166,1.1237766263673,0.4901447390590789,['CALCR'],0.9209792549979274,0,0,1
210,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.6465152386078166,1.1237766263673,0.4901447390590789,['BAX'],0.9209792549979274,0,0,1
211,Regulation of Microtubule Cytoskeleton WP2038,0.6465152386078166,1.1237766263673,0.4901447390590789,['CFL2'],0.9209792549979274,0,0,1
212,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.6465152386078166,1.1237766263673,0.4901447390590789,['ANAPC11'],0.9209792549979274,0,0,1
213,Circadian rhythm related genes WP3594,0.6727401507184231,0.8860411899313501,0.3512232985424985,"['AHCY', 'HOMER1', 'CRH', 'RPS27A', 'UBA52']",0.9349393075095223,0,0,5
214,EGF/EGFR signaling pathway WP437,0.7024828706116238,0.8418544194107452,0.29728763872491704,"['NDUFA13', 'HRAS', 'AP2M1']",0.9349393075095223,0,0,3
215,Insulin Signaling WP481,0.7024828706116238,0.8418544194107452,0.29728763872491704,"['XBP1', 'HRAS', 'VAMP2']",0.9349393075095223,0,0,3
216,22q11.2 copy number variation syndrome WP4657,0.7053337308769273,0.842128027681661,0.2939735981438882,"['RANBP1', 'MRPL40']",0.9349393075095223,0,0,2
217,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.7053337308769273,0.842128027681661,0.2939735981438882,"['TMSB4X', 'SOD1']",0.9349393075095223,0,0,2
218,Chemokine signaling pathway WP3929,0.7053337308769273,0.842128027681661,0.2939735981438882,"['CXCL12', 'HRAS']",0.9349393075095223,0,0,2
219,Prader-Willi and Angelman Syndrome WP3998,0.7053337308769273,0.842128027681661,0.2939735981438882,"['GABRR2', 'SNURF']",0.9349393075095223,0,0,2
220,7-oxo-C and 7beta-HC pathways WP5064,0.7275189975653567,0.8424006908462867,0.26798043626882195,['ACOT11'],0.9349393075095223,0,0,1
221,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.7275189975653567,0.8424006908462867,0.26798043626882195,['HRAS'],0.9349393075095223,0,0,1
222,ATM Signaling Network in Development and Disease  WP3878,0.7275189975653567,0.8424006908462867,0.26798043626882195,['KAT5'],0.9349393075095223,0,0,1
223,CAMKK2  Pathway WP4874,0.7275189975653567,0.8424006908462867,0.26798043626882195,['FIS1'],0.9349393075095223,0,0,1
224,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.7275189975653567,0.8424006908462867,0.26798043626882195,['FADD'],0.9349393075095223,0,0,1
225,Cardiac Progenitor Differentiation WP2406,0.7275189975653567,0.8424006908462867,0.26798043626882195,['MESP1'],0.9349393075095223,0,0,1
226,DNA Mismatch Repair WP531,0.7275189975653567,0.8424006908462867,0.26798043626882195,['POLE3'],0.9349393075095223,0,0,1
227,Endothelin Pathways WP2197,0.7275189975653567,0.8424006908462867,0.26798043626882195,['NPY1R'],0.9349393075095223,0,0,1
228,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.7275189975653567,0.8424006908462867,0.26798043626882195,['IGFBP5'],0.9349393075095223,0,0,1
229,Heart Development WP1591,0.7275189975653567,0.8424006908462867,0.26798043626882195,['VEGFB'],0.9349393075095223,0,0,1
230,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.7275189975653567,0.8424006908462867,0.26798043626882195,['DDIT3'],0.9349393075095223,0,0,1
231,IL-6 signaling pathway WP364,0.7275189975653567,0.8424006908462867,0.26798043626882195,['VIP'],0.9349393075095223,0,0,1
232,Integrin-mediated Cell Adhesion WP185,0.7275189975653567,0.8424006908462867,0.26798043626882195,['HRAS'],0.9349393075095223,0,0,1
233,Joubert Syndrome WP4656,0.7275189975653567,0.8424006908462867,0.26798043626882195,['KAT5'],0.9349393075095223,0,0,1
234,NO/cGMP/PKG mediated Neuroprotection WP4008,0.7275189975653567,0.8424006908462867,0.26798043626882195,['CYCS'],0.9349393075095223,0,0,1
235,Pre-implantation embryo WP3527,0.7275189975653567,0.8424006908462867,0.26798043626882195,['DDIT3'],0.9349393075095223,0,0,1
236,Ebola Virus Pathway on Host WP4217,0.75592735161498,0.7481737793156479,0.20934650756013476,"['HLA-B', 'CLEC4G']",0.9423764879225607,0,0,2
237,Glioblastoma signaling pathways WP2261,0.75592735161498,0.7481737793156479,0.20934650756013476,"['BRCA1', 'HRAS']",0.9423764879225607,0,0,2
238,Oxidative Damage WP3941,0.75592735161498,0.7481737793156479,0.20934650756013476,"['GADD45A', 'CYCS']",0.9423764879225607,0,0,2
239,Peptide GPCRs WP24,0.75592735161498,0.7481737793156479,0.20934650756013476,"['NPY1R', 'OPRK1']",0.9423764879225607,0,0,2
240,NRF2 pathway WP2884,0.7769428096649377,0.7472993827160493,0.18860979667781214,"['PRDX1', 'GSTP1', 'MAFF', 'SLC2A12']",0.9423764879225607,0,0,4
241,Small cell lung cancer WP4658,0.7834158214949186,0.7208467442436246,0.17595267986417298,"['GADD45A', 'CYCS', 'BAX']",0.9423764879225607,0,0,3
242,Complement system WP2806,0.7834158214949186,0.7208467442436246,0.17595267986417298,"['RPS19', 'CD59', 'CALR']",0.9423764879225607,0,0,3
243,Proximal tubule transport WP4917,0.7834158214949186,0.7208467442436246,0.17595267986417298,"['ATP6V1G1', 'SLC13A3', 'ATP6V1F']",0.9423764879225607,0,0,3
244,Alpha 6 Beta 4 signaling pathway WP244,0.7899847172574119,0.6735751295336787,0.1587897319365627,['HRAS'],0.9423764879225607,0,0,1
245,Aryl Hydrocarbon Receptor Netpath WP2586,0.7899847172574119,0.6735751295336787,0.1587897319365627,['HRAS'],0.9423764879225607,0,0,1
246,Toll-like Receptor Signaling Pathway WP75,0.7899847172574119,0.6735751295336787,0.1587897319365627,['FADD'],0.9423764879225607,0,0,1
247,DNA IR-damage and cellular response via ATR WP4016,0.7899847172574119,0.6735751295336787,0.1587897319365627,['BRCA1'],0.9423764879225607,0,0,1
248,Genes controlling nephrogenesis WP4823,0.7899847172574119,0.6735751295336787,0.1587897319365627,['CXCL12'],0.9423764879225607,0,0,1
249,Hypertrophy Model WP516,0.7899847172574119,0.6735751295336787,0.1587897319365627,['IL1R1'],0.9423764879225607,0,0,1
250,Nucleotide Excision Repair WP4753,0.7899847172574119,0.6735751295336787,0.1587897319365627,['POLE3'],0.9423764879225607,0,0,1
251,Oxysterols derived from cholesterol WP4545,0.7899847172574119,0.6735751295336787,0.1587897319365627,['ACOT11'],0.9423764879225607,0,0,1
252,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.7899847172574119,0.6735751295336787,0.1587897319365627,['BAX'],0.9423764879225607,0,0,1
253,B Cell Receptor Signaling Pathway WP23,0.7988356983714422,0.6730103806228374,0.1511581237077166,"['ETS1', 'HRAS']",0.9423764879225607,0,0,2
254,Gastrin signaling pathway WP4659,0.7988356983714422,0.6730103806228374,0.1511581237077166,"['KAT5', 'HRAS']",0.9423764879225607,0,0,2
255,Pancreatic adenocarcinoma pathway WP4263,0.7988356983714422,0.6730103806228374,0.1511581237077166,"['GADD45A', 'BAX']",0.9423764879225607,0,0,2
256,Regulation of Actin Cytoskeleton WP51,0.7988356983714422,0.6730103806228374,0.1511581237077166,"['CFL2', 'TMSB4X']",0.9423764879225607,0,0,2
257,Adipogenesis WP236,0.8165334686493402,0.6724436741767764,0.13629584451709792,"['GADD45A', 'DDIT3', 'MIF']",0.9480189955866796,0,0,3
258,Ras signaling WP4223,0.8165334686493402,0.6724436741767764,0.13629584451709792,"['CALM3', 'ETS1', 'HRAS']",0.9480189955866796,0,0,3
259,MAPK Signaling Pathway WP382,0.8279616241452482,0.6996376811594203,0.13208352970437182,"['MAPKAPK3', 'IL1R1', 'GADD45A', 'DDIT3', 'HRAS']",0.9480189955866796,0,0,5
260,Breast cancer pathway WP4262,0.8342227308244496,0.671875,0.12178060163141947,"['GADD45A', 'BAX', 'BRCA1', 'HRAS']",0.9480189955866796,0,0,4
261,TGF-beta Signaling Pathway WP366,0.8349211808673586,0.6115130544196288,0.1103279333628872,"['YAP1', 'ETS1']",0.9480189955866796,0,0,2
262,Aryl Hydrocarbon Receptor Pathway WP2873,0.8381492444425279,0.5610247553252734,0.09905402495999767,['BAX'],0.9480189955866796,0,0,1
263,Type II interferon signaling (IFNG) WP619,0.8381492444425279,0.5610247553252734,0.09905402495999767,['HLA-B'],0.9480189955866796,0,0,1
264,G13 Signaling Pathway WP524,0.8381492444425279,0.5610247553252734,0.09905402495999767,['CFL2'],0.9480189955866796,0,0,1
265,Hepatitis C and Hepatocellular Carcinoma WP3646,0.8381492444425279,0.5610247553252734,0.09905402495999767,['BRCA1'],0.9480189955866796,0,0,1
266,IL-3 signaling pathway WP286,0.8381492444425279,0.5610247553252734,0.09905402495999767,['HRAS'],0.9480189955866796,0,0,1
267,Prolactin Signaling Pathway WP2037,0.8381492444425279,0.5610247553252734,0.09905402495999767,['HRAS'],0.9480189955866796,0,0,1
268,"GPCRs, Class A Rhodopsin-like WP455",0.8504798472767007,0.671304347826087,0.10872080200678046,"['NPFFR1', 'NPY1R', 'OPRK1', 'OR6A2', 'ADRA2A']",0.9542789992348726,0,0,5
269,Spinal Cord Injury WP2431,0.8699843271684696,0.5927209705372617,0.08255422552456491,"['IL1R1', 'GADD45A', 'MIF']",0.9542789992348726,0,0,3
270,Bladder cancer WP2828,0.8752823933379461,0.48063163089069827,0.0640243192713045,['HRAS'],0.9542789992348726,0,0,1
271,Corticotropin-releasing hormone signaling pathway WP2355,0.8752823933379461,0.48063163089069827,0.0640243192713045,['CRH'],0.9542789992348726,0,0,1
272,ESC Pluripotency Pathways WP3931,0.8752823933379461,0.48063163089069827,0.0640243192713045,['HRAS'],0.9542789992348726,0,0,1
273,Glycogen Synthesis and Degradation WP500,0.8752823933379461,0.48063163089069827,0.0640243192713045,['CALM3'],0.9542789992348726,0,0,1
274,Hippo-Merlin Signaling Dysregulation WP4541,0.8752823933379461,0.48063163089069827,0.0640243192713045,['HRAS'],0.9542789992348726,0,0,1
275,Monoamine GPCRs WP58,0.8752823933379461,0.48063163089069827,0.0640243192713045,['ADRA2A'],0.9542789992348726,0,0,1
276,Nephrotic syndrome WP4758,0.8752823933379461,0.48063163089069827,0.0640243192713045,['CUBN'],0.9542789992348726,0,0,1
277,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.8752823933379461,0.48063163089069827,0.0640243192713045,['NDUFA13'],0.9542789992348726,0,0,1
278,Vitamin D Receptor Pathway WP2877,0.8786794425705884,0.6101641414141414,0.0789156597900488,"['IGFBP5', 'GADD45A', 'SOSTDC1', 'ZNF257']",0.9545366606342363,0,0,4
279,Cell cycle WP179,0.8911618446190884,0.5595031773541306,0.06447111707183854,"['GADD45A', 'CDC14A', 'ANAPC11']",0.9645937294977628,0,0,3
280,ErbB signaling pathway WP673,0.9039073690326718,0.42033678756476683,0.042465949630254664,['HRAS'],0.9645937294977628,0,0,1
281,G Protein Signaling Pathways WP35,0.9039073690326718,0.42033678756476683,0.042465949630254664,['HRAS'],0.9645937294977628,0,0,1
282,G1 to S cell cycle control WP45,0.9039073690326718,0.42033678756476683,0.042465949630254664,['GADD45A'],0.9645937294977628,0,0,1
283,Neural Crest Differentiation WP2064,0.9039073690326718,0.42033678756476683,0.042465949630254664,['ETS1'],0.9645937294977628,0,0,1
284,T-cell receptor (TCR) signaling pathway WP69,0.9259710152307619,0.37344079831126464,0.028722207842633102,['HRAS'],0.9694196897332661,0,0,1
285,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9259710152307619,0.37344079831126464,0.028722207842633102,['HMGCS1'],0.9694196897332661,0,0,1
286,Endochondral Ossification WP474,0.9259710152307619,0.37344079831126464,0.028722207842633102,['HMGCS1'],0.9694196897332661,0,0,1
287,Regulation of toll-like receptor signaling pathway WP1449,0.9259710152307619,0.37344079831126464,0.028722207842633102,['FADD'],0.9694196897332661,0,0,1
288,Retinoblastoma gene in cancer WP2446,0.9259710152307619,0.37344079831126464,0.028722207842633102,['H2AFZ'],0.9694196897332661,0,0,1
289,Allograft Rejection WP2328,0.9276897030891188,0.447520184544406,0.033589958278367686,"['CXCL12', 'HLA-B']",0.9694196897332661,0,0,2
290,Calcium Regulation in the Cardiac Cell WP536,0.9373731868856031,0.4788313939093835,0.0309678446585518,"['RGS16', 'CALM3', 'CALR']",0.9719404045341367,0,0,3
291,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.9415841677685746,0.4193339100346021,0.02524035271087894,"['PSMD8', 'STUB1']",0.9719404045341367,0,0,2
292,Wnt signaling pathway and pluripotency WP399,0.9429752931407352,0.33592400690846286,0.019723844231523496,['LDLR'],0.9719404045341367,0,0,1
293,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9429752931407352,0.33592400690846286,0.019723844231523496,['HRAS'],0.9719404045341367,0,0,1
294,Metapathway biotransformation Phase I and II WP702,0.9529175491457486,0.3944636678200692,0.01902375837508292,"['GPX4', 'GSTP1']",0.9733914054786302,0,0,2
295,TYROBP causal network in microglia WP3945,0.9560788074616966,0.3052284503061705,0.01370931592779308,['LOXL3'],0.9733914054786302,0,0,1
296,Ciliopathies WP4803,0.9560788074616966,0.3052284503061705,0.01370931592779308,['AK7'],0.9733914054786302,0,0,1
297,Focal Adhesion WP306,0.9572756537322953,0.43674176776429807,0.01906984432127552,"['VEGFB', 'HRAS', 'MYL12B']",0.9733914054786302,0,0,3
298,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9845607972978222,0.22337363270005758,0.0034756107006827367,['HRAS'],0.9957398017697763,0,0,1
299,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9875886152340876,0.2906574394463668,0.0036300350868985155,"['CDCA7L', 'VAMP2']",0.9957398017697763,0,0,2
300,Nuclear Receptors Meta-Pathway WP2882,0.9891454984467977,0.40593849416755035,0.004430348363468828,"['PRDX1', 'GSTP1', 'SLC2A12', 'MAFF', 'BAX']",0.9957398017697763,0,0,5
301,PI3K-Akt signaling pathway WP4172,0.9980981111939435,0.26229134361032563,0.0004993239503092267,"['VEGFB', 'BRCA1', 'HRAS']",0.9987850108533812,0,0,3
302,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9987850108533812,0.20153087973157177,0.0002450067019824753,"['VEGFB', 'HRAS']",0.9987850108533812,0,0,2
